Trial
NCT06028230
A Phase 2 Study to Evaluate the Efficacy and Safety of SAR444656 Compared With Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Sanofi
Collaborators
Kymera Therapeutics, Inc.
Condition
Hidradenitis Suppurativa
Intervention
SAR444656 (KT-474)
Why stopped
Sponsor decision. Not related to safety concern.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-12-11